EN
登录

Stryker推出PROstep®MIS Lapidus,这是一种治疗Bunion患者的新型微创手术选择

Stryker Launches PROstep ® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

businesswire 等信源发布 2023-09-19 19:20

可切换为仅中文


KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal cuneiform joint.

密歇根州卡拉马祖(BUSINESS WIRE)-世界领先的医疗技术公司之一Stryker(NYSE:SYK)宣布推出PROstep®MISLAPIDUS,这是一种新型内固定系统,旨在使用微创手术治疗拇外翻畸形并随后融合第一跖骨楔形关节。

The system will debut at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Louisville, Ky., Sept. 20-23 (booth no. 101)..

该系统将于9月20日至23日在肯塔基州路易斯维尔举行的美国骨科足踝协会(AOFAS)年会上首次亮相(第101号展台)。。

Traditionally, surgeons performing Lapidus bunion procedures use an open approach, but minimally invasive surgery techniques are being adopted in numerous surgical specialties because of the surgeon and patient advantages.1,2 PROstep MIS Lapidus offers powerful fixation stability through a minimal incision.

传统上,执行Lapidus bunion手术的外科医生使用开放式方法,但由于外科医生和患者的优势,许多外科专科正在采用微创手术技术.1,2 PROstep MIS Lapidus通过最小切口提供强大的固定稳定性。

The new technology features MIS joint preparation, triplanar reduction, and a three-screw construct designed to create a tension band for biomechanical stability..

新技术具有错位关节准备,三平面缩小和三螺钉结构,旨在为生物力学稳定性创造张力带。。

“This procedure can be a better option for patients who are worried about cosmetic scarring from surgery and can mitigate the potential loss of correction caused by improper bone healing,” said Dr. Alastair Younger, Head of the Distal Extremities Division at the University of British Columbia. “I appreciate having a viable minimally invasive surgery option that provides surgeons and their patients more options for treating bunions.”.

不列颠哥伦比亚大学远端部负责人Alastair Younger博士说:“对于担心手术造成美容瘢痕并且可以减轻因骨愈合不当而导致的矫正损失的患者,这种手术可能是更好的选择。”哥伦比亚。“我非常感谢有一种可行的微创手术方案,为外科医生和患者提供更多治疗拇囊炎的选择。”。

Benefits of the PROstep MIS Lapidus system include:

PROstep MIS Lapidus系统的好处包括:

2.5% decrease in recurrence compared to open Lapidus procedures3

与开放式Lapidus手术相比,复发率降低2.5%3

9% reduction in non-union rates as a result of MIS Lapidus joint preparation3

由于MIS Lapidus联合准备,非工会率降低9%3

76% reduction in scar size compared to open bunion correction procedures4

Less opioid usage post-op compared to open Lapidus procedures5

与开放式Lapidus程序相比,术后阿片类药物使用较少5

“PROstep MIS Lapidus puts the power back in our surgeon customers' hands to make the best decision for their patients,” said Patrick Fisher, Vice President and General Manager for Stryker’s Foot and Ankle business unit. “At Stryker, we're continuing to expand our surgery options to support our commitment to advancing minimally invasive foot and ankle surgery.”.

Stryker足踝业务部门副总裁兼总经理Patrick Fisher说:“PROstep MIS Lapidus将权力放回外科医生客户手中,为患者做出最佳决定。”。“在Stryker,我们正在继续扩大我们的手术选择,以支持我们致力于推进微创足踝手术。”。

Stryker will host the PROstep MIS Lapidus Lab at AOFAS on Sept. 21 from 12:30-2:00 p.m., in the Stryker mobile lab at the Exhibit Hall. Design surgeons Dr. Alastair Younger and Dr. Steven Steinlauf will also be available to meet with attendees during the Meet the Experts session to demonstrate PROstep MIS Lapidus, at Stryker’s booth no.

Stryker将于9月21日下午12:30-2:00在AOFAS举办PROstep MIS Lapidus实验室,在展览厅的Stryker移动实验室。设计外科医生Alastair Younger博士和Steven Steinlauf博士也将在专家会议期间与与会者会面,在Stryker的展台上展示PROstep MIS Lapidus。

101, on Sept. 20 at 5-6 p.m., Sept. 21 at 10-10:45 a.m., and Sept. 22 at 1-2 p.m. ET..

101,9月20日下午5-6点,9月21日上午10-10:45,9月22日下午1-2点。。

Additionally at AOFAS, Stryker will be debuting the 4WEB Cotton, Evans, and Utility wedge implants and instruments, which are part of the 4WEB Osteotomy Truss System™ (OTS). Stryker is now the exclusive distributor of the OTS that contains the wedge implants for osteotomies of the foot. OTS has an advanced structural design that incorporates 4WEB Medical’s proprietary Truss Implant Technology™..

此外,在AOFAS,Stryker将推出4WEB Cotton,Evans和实用楔形植入物和器械,它们是4WEB截骨-骨骼系统的一部分™ (OTS)。Stryker现在是OTS的独家分销商,其中包含用于足部截骨术的楔形植入物。OTS具有先进的结构设计,结合了4WEB Medical专有的Truss植入技术™..

About Stryker

关于Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes.

Stryker是世界领先的医疗技术公司之一,与其客户一起,推动医疗保健更好。该公司在医疗和外科,神经技术,骨科和脊柱方面提供创新产品和服务,帮助改善患者和医疗保健结果。

Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com..

除了全球客户外,Stryker每年影响超过1.3亿患者。更多信息请访问www.stryker.com。。

Follow Stryker Foot & Ankle on LinkedIn.

按照LinkedIn上的Stryker脚和脚踝。

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery..

在决定是否在治疗特定患者时使用特定产品时,外科医生必须始终依靠他或她自己的专业临床判断。Stryker不会提供医疗建议,并建议外科医生在手术前使用任何特定产品进行培训。。

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets.

所提供的信息旨在展示Stryker产品的广度。在使用任何Stryker产品之前,外科医生必须始终参考包装说明书,产品标签和/或使用说明。产品可能并非在所有市场上都可用,因为产品可用性取决于个别市场的监管和/或医疗实践。

Please contact your sales representative if you have questions about the availability of products in your area..

如果您对所在地区的产品可用性有任何疑问,请联系您的销售代表。。

References:

参考文献:

Trnka HJ, Krenn S, Schuh R. Minimally Invasive Hallux Valgus Surgery: a Critical Review of the Evidence. International Orthopaedics 2013; 37: 1731-1735.

Trnka HJ,Krenn S,Schuh R.微创拇外翻手术:对证据的批判性评论。国际骨科2013;37: 1731-1735.

Brogan K, Lindisfarne E, Akehurts H, Farook U, Shrier W, Palmer S. Minimally Invasive and Open Distal Chevron Osteotomy for Mild to Moderate Hallux Valgus. Foot Ankle Intl 2016; 37 (11): 1197-1204.

Brogan K,Lindisfarne E,Akhorks H,Farook U,Shrier W,Palmer S.微创和开放式远端人字形截骨术治疗轻度至中度拇外翻。足踝Intl 2016;37 (11): 1197-1204.

Diogo, V.C., Velijkovi, A., Wing, K., Penner, M., Gagne, O., & Younger, A (2022). Cohort Comparison of Radiographic Correction and Complications between Minimal Invasive and Open Lapidus Procedures for Hallux Valgus. Foot & Ankle International, 43(10), 1277-1284. https://doi.org/10.1177/10711007221112088..

Diogo,V.C.,Velijkovi,A.,Wing,K.,Penner,M.,Gagne,O。,&Younger,A(2022)。微创和开放式Lapidus手术治疗拇外翻的影像学矫正和并发症的队列比较。Foot&Ankle International,43(10),1277-1284。https://doi.org/10.1177/10711007221112088..

Lam P, Lee M, Xing J, & Di Nallo M (2016). Percutaneous Surgery for Mild to Moderate Hallux Valgus. Foot & Ankle Clinics N Am, 21(3), 459-477 (data only with respect to chevron osteotomy procedure)

Lam P,Lee M,Xing J,&Di Nallo M(2016)。经皮手术治疗轻度至中度拇外翻。足踝诊所N Am,21(3),459-477(仅关于人字形截骨术的数据)

Jimmy J. Chan, MD; Javier Z. Guzman, MD; Andrea Nordio, MD; Jesse C. Chan; Carl M. Cirino, MD; Ettore Vulcano, MD. Opioid Consumption and Time to Return to Work After Percutaneous Osteotomy in Foot Surgery. Orthopedics. May 7, 2020.

Jimmy J.Chan,医学博士;Javier Z.Guzman,医学博士;医学博士Andrea Nordio;Jesse C.Chan;Carl M.Cirino,医学博士;Ettore Vulcano,医学博士。足部手术中经皮截骨术后阿片类药物的消耗和重返工作岗位的时间。骨科。2020年5月7日。